EPAC vs PSIX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
EPAC presents a stark contrast between a healthy balance sheet and a severely overvalued market price. While the Piotroski F-Score of 4/9 indicates stable financial health and the company maintains strong margins and low debt, the stock is trading at a massive premium to its Graham Number ($16.82) and Intrinsic Value ($11.13). This valuation gap is exacerbated by negative earnings growth (-18.4% YoY) and a completely bearish technical trend (0/100). Despite strong ROE, the lack of earnings momentum and the significant distance from defensive fair value suggest limited upside and high downside risk.
PSIX exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and exceptional liquidity (Current Ratio 3.15). While the company shows aggressive revenue growth (32.5%) and an extraordinary ROE (93.49%), there is a concerning divergence as YoY earnings growth has plummeted by 31.6%. The stock is currently trading at a significant premium to its Graham Number ($29.35) and Intrinsic Value ($34.58), suggesting the market has priced in substantial future growth that is not yet reflected in the bottom-line earnings trend.
Compare Another Pair
Related Comparisons
EPAC vs PSIX: Head-to-Head Comparison
This page compares Enerpac Tool Group Corp. (EPAC) and Power Solutions International, Inc. (PSIX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.